Editorial
Standards

Peptide Protocols Research Team is the organizational byline used for research developed collaboratively by our researchers, editors, and technical contributors. The team is responsible for defining the question, reviewing the evidence, checking factual claims, explaining limitations, and approving the final publication.

An organizational byline does not imply that every contributor holds the same credentials or that an article provides medical advice. When an individual author or reviewer is materially responsible and public attribution is appropriate, that information may be listed separately.

Peptide Protocols content is not routinely medically reviewed unless a page explicitly identifies a qualified reviewer. The Peptide Protocols Research Team organizational byline does not represent a physician, pharmacist, or other licensed healthcare professional.

When a qualified professional reviews an article, their name, relevant credentials, and review date are displayed on that page. The absence of a named medical reviewer means readers should not infer that medical review occurred.

We prioritize sources closest to the underlying evidence: peer-reviewed research, clinical-trial registries, regulator and manufacturer documents, laboratory-issued records, and other primary materials. Current systematic reviews or authoritative technical guidance may be used to establish context.

Commercial articles, vendor claims, press releases, preprints, and anecdotal reports may be discussed when they are the subject of the analysis, but they are labeled according to their evidence status. We do not treat repetition across secondary sources as independent confirmation.

We distinguish approved prescribing information, clinical-trial protocols, preclinical research, and community-derived practices. A clinical-trial dose is described as a study design, not automatically as a treatment recommendation. When no validated human dose exists, community ranges are labeled as community-derived and are not presented as clinically established protocols.

Animal doses are reported as species-specific research conditions and are not converted into human instructions. In-vitro concentrations describe laboratory experiments, not dosing. Personal experience from Peptide Protocols contributors is treated as anecdotal evidence and labeled accordingly.

Our evidence hierarchy, from strongest regulatory or human-use foundation to the most exploratory, is:

A laboratory logo or favorable percentage is not enough. We examine whether the issuing laboratory can be identified, whether the report can be verified through a provider-controlled system where available, and whether report identifiers, dates, sample details, methods, and results form a coherent record.

We also distinguish what each method can establish. Identity, chromatographic purity, quantitative content, sterility, endotoxin, aggregation, particles, and biological potency are separate questions. A report receives credit only for the measurements it actually contains.

AI tools may assist with document organization, source comparison, transcription, drafting, editing, and consistency checks. AI-produced language is treated as draft material—not as evidence and not as an editorial decision.

Factual claims must be traceable to reviewed sources. The Research Team is responsible for checking citations, resolving discrepancies, preserving uncertainty, and removing unsupported statements. AI does not autonomously determine conclusions, assign COA grades, or publish articles.

A human member of the Peptide Protocols Research Team makes the final editorial decision. That review covers the article’s scope, headline, source selection, interpretation, limitations, internal links, visual claims, and publication readiness.

Commercial relationships, affiliate participation, vendor status, or sponsor preferences do not grant a source control over conclusions or final wording. When the available evidence cannot support a confident answer, the published conclusion should say so.

Readers, laboratories, researchers, and vendors may report a possible error through the site’s Support form or by emailing info@peptideprotocols.app. A useful correction request identifies the page, disputed statement, and primary source or report details needed to verify the issue.

We check the claim against the underlying evidence and update confirmed errors. Material corrections may include a revised review date or an explanatory correction note when readers need context about what changed. Minor spelling, formatting, or link repairs may be made without a formal note when they do not alter meaning.

Requests are evaluated on evidence, not on whether a correction is favorable to Peptide Protocols, a vendor, or another interested party.